Orentreich N, Brind JL, Rizer RL, et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984; 59:551–555.
Be’langer A, Candas B, Dupont A, et al. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year old men. J Clin Endocrinol Metab 1994; 79:1086–1090.
Wolkowitz OM, Epel, ES, Reus VI. Stress hormone-related psychopathology: pathophysiological and treatment implications. World J Biol Psychiatry 2001; 2:115–143.
Straub RH, Lehle K, Herfarth H, Weber, et al. Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumour necrosis factor. Eur J Endocrinol 2002; 146:365–374.
Sapolsky RM. Stress, the aging brain and the mechanism of neuron death. Cambridge, MA: MIT, 1992.
Seals DR, Esler M. Human ageing and the sympathoadrenal system. J Physiol 2000; 528:407–417.
Esler M, Lambert G, Kaye D, et al. Influence of ageing on the sympathetic nervous system and adrenal medulla at rest and during stress. Biogerontology 2002; 3:45–49.
Bastianetto S, Ramassamy C, Poirier, et al. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res 1999; 66:35–41.
Cardounel A, Regelson W, Kalimi M. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc Soc Exp Biol Med 1999; 22:145–149.
Lapchak PA, Chapman DF, Nunez SY, et al. Dehydroepiandrosterone sulfate is neuroprotective in a reversible spinal cord ischemia model: possible involvement of GABA(A) receptors. Stroke 2000; 31:1953–1956.
Kimonides VG, Khatibi NH, Svendsen CN, et al. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci USA 1998; 95:1852–1857.
Weill-Engerer S, David JP, Sazdovitch V, et al. Neurosteroid quantification in human brain regions: comparison between Alzheimer’s and nondemented patients. J Clin Endocrinol Metab 2002; 87:5138–5143.
Schumacher M, Weill-Engerer S, Liere P, et al. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol 2003; 71:3–29.
Belanger N, Gregoire L, Bedard P, et al. Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine monkeys. Endocrine 2003; 1:97–101.
Belanger N, Gregoire L, Bedard PJ, et al. DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys. Neurobiol Aging 2006; 11:1684–1693.
Charalampopoulos I, Tsatsanis C, Dermitzaki E, et al. Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal cells against apoptosis, via Bcl-2 antiapoptotic proteins. Proc Natl Acad Sci USA 2004; 101:8209–8214.
Riccio A, Ahn S, Davenport CM, et al. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 1999; 286:2358–2361.
Tamatani M, Che YH, Matsuzaki H, et al. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem 1999; 274:8531–8538.
Ruvolo P, Deng X, Carr B, et al. A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 1998; 273:25436–25442.
Charalampopoulos I, Alexaki VI, Lazaridis I, et al. G protein-associated, specific membrane binding sites mediate the neuroprotective effect of Dehydroepiandrosterone. FASEB J 2006; 20:577–579.
Wooten M, Seibenhener ML, Neidich K, et al. Mapping of atypical protein kinase C within the nerve growth factor signaling cascade: relationship to differentiation and survival of PC12 cells. Mol Cell Biol 2000; 20:4494–4504.
Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 2005; 2:141–194.
Sapolsky RM. Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels. J Neurosci 1986; 6:2240–2244.
Sapolsky RM, Krey LC, McEwen BC. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocrine Revs 1986; 7:284–301.
Marder K, Tang MX, Mejia H, et al. Risk of Parkinson’s disease among first-degree relatives: a community-based study. Neurology 1996; 47:155–160.
Yang SH, Perez E, Cutright J, et al. Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model. J Appl Physiol 2002; 1:195–201.
Swaab DF, Raadsheer FC, Endert E, et al. Increased cortisol levels in aging and Alzheimer’s disease in postmortem cerebrospinal fluid. J Neuroendocrinol 1994; 6:681–687.
Umegaki H, Ikari H, Nakahata H, et al. Plasma cortisol levels in elderly female subjects with Alzheimer’s disease: a cross-sectional and longitudinal study. Brain Res 2000; 881:241–243.
Mattson M. Apoptosis in neurodegenerative disorders. Nature Rev Mol Cell Biol 2000; 1:120–129.
Kratnic S, Mechawar N, Reix S, et al. Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci 2006; 28:670–676.
Forman MS, Trojanowski J, Lee V. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nature Med 2004; 10:1055–1063.
Charalampopoulos I, Dermitzaki E, Vardouli L, et al. Dehydroepiandrosterone and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization. Endocrinology 2005; 146:3309–3318.